109 related articles for article (PubMed ID: 29798000)
1. [The clinicopathological associations between TGF-β1 and papillary thyroid carcinoma: a Meta-analysis.].
Xu Y; Ma L; Zhang GA; Wang W; Zhang RY; Hou S; Cui W
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 Sep; 31(18):1431-1435. PubMed ID: 29798000
[No Abstract] [Full Text] [Related]
2. Expression of TGF-β1, SNAI1 and MMP-9 is associated with lymph node metastasis in papillary thyroid carcinoma.
Wang N; Jiang R; Yang JY; Tang C; Yang L; Xu M; Jiang QF; Liu ZM
J Mol Histol; 2014 Aug; 45(4):391-9. PubMed ID: 24276590
[TBL] [Abstract][Full Text] [Related]
3. Transforming Growth Factor β1 Could Influence Thyroid Nodule Elasticity and Also Improve Cervical Lymph Node Metastasis in Papillary Thyroid Carcinoma.
Li Y; Wang Y; Wu Q; Hu B
Ultrasound Med Biol; 2015 Nov; 41(11):2866-72. PubMed ID: 26306431
[TBL] [Abstract][Full Text] [Related]
4. Upregulation of lncRNA-ATB by Transforming Growth Factor β1 (TGF-β1) Promotes Migration and Invasion of Papillary Thyroid Carcinoma Cells.
Cui M; Chang Y; Du W; Liu S; Qi J; Luo R; Luo S
Med Sci Monit; 2018 Jul; 24():5152-5158. PubMed ID: 30042377
[TBL] [Abstract][Full Text] [Related]
5. Notch and TGF-β/Smad3 pathways are involved in the interaction between cancer cells and cancer-associated fibroblasts in papillary thyroid carcinoma.
Zhang J; Wang Y; Li D; Jing S
Tumour Biol; 2014 Jan; 35(1):379-85. PubMed ID: 23918305
[TBL] [Abstract][Full Text] [Related]
6. Expression of transforming growth factor-beta1 and transforming growth factor-beta Type-II receptor mRNA in papillary thyroid carcinoma.
Matoba H; Sugano S; Yamaguchi N; Miyachi Y
Horm Metab Res; 1998 Oct; 30(10):624-8. PubMed ID: 9851670
[TBL] [Abstract][Full Text] [Related]
7. FoxP3 in papillary thyroid carcinoma induces NIS repression through activation of the TGF-β1/Smad signaling pathway.
Ma S; Wang Q; Ma X; Wu L; Guo F; Ji H; Liu F; Zhao Y; Qin G
Tumour Biol; 2016 Jan; 37(1):989-98. PubMed ID: 26264613
[TBL] [Abstract][Full Text] [Related]
8. LDOC1 inhibits proliferation and promotes apoptosis by repressing NF-κB activation in papillary thyroid carcinoma.
Zhao S; Wang Q; Li Z; Ma X; Wu L; Ji H; Qin G
J Exp Clin Cancer Res; 2015 Dec; 34():146. PubMed ID: 26637328
[TBL] [Abstract][Full Text] [Related]
9. Relationship between expression of vascular endothelial growth factor and cervical lymph node metastasis in papillary thyroid cancer: A meta-analysis.
Huang XQ; He WS; Zhang HQ; Yang R; Huang T
J Huazhong Univ Sci Technolog Med Sci; 2017 Oct; 37(5):661-666. PubMed ID: 29058277
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-451 as a prognostic marker for diagnosis and lymph node metastasis of papillary thyroid carcinoma.
Zhang M; Wu W; Gao M; Fei Z
Cancer Biomark; 2017 Jul; 19(4):437-445. PubMed ID: 28582849
[TBL] [Abstract][Full Text] [Related]
11. [Pathologic study of expression and significance of matrix metalloproteinases-9, tissue inhibitor of metalloproteinase-1, vascular endothelial growth factor and transforming growth factor beta-1 in papillary carcinoma and follicular carcinoma of thyroid].
Wang T; Jiang CX; Li Y; Liu X
Zhonghua Bing Li Xue Za Zhi; 2009 Dec; 38(12):824-8. PubMed ID: 20193458
[TBL] [Abstract][Full Text] [Related]
12. [The expression and significance of trefoil factor 3 and SDF-1/CXCR4 biological axis in papillary thyroid carcinoma].
Xue G; Huang J; Zhang H; Zhang W; Wu J; Shang X
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2014 Jan; 28(2):108-12. PubMed ID: 24738314
[TBL] [Abstract][Full Text] [Related]
13. Stomatin-like protein 2 is associated with the clinicopathological features of human papillary thyroid cancer and is regulated by TGF-β in thyroid cancer cells.
Liu Z; Yang Y; Zhang Y; Ye X; Wang L; Xu G
Oncol Rep; 2014 Jan; 31(1):153-60. PubMed ID: 24190591
[TBL] [Abstract][Full Text] [Related]
14. Increased expression of vascular endothelial growth factor C in papillary thyroid carcinoma correlates with cervical lymph node metastases.
Yu XM; Lo CY; Chan WF; Lam KY; Leung P; Luk JM
Clin Cancer Res; 2005 Nov; 11(22):8063-9. PubMed ID: 16299237
[TBL] [Abstract][Full Text] [Related]
15. [Expression and clinical significance of Nrf2 and ERK pathway in papillary thyroid carcinoma].
Chen YM; Wei L; Lin X; Zhang WJ; Wu JF; Xue G
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 Jun; 31(12):941-945. PubMed ID: 29798417
[No Abstract] [Full Text] [Related]
16. Loss of cellular polarity/cohesiveness in the invasive front of papillary thyroid carcinoma, a novel predictor for lymph node metastasis; possible morphological indicator of epithelial mesenchymal transition.
Liu Z; Kakudo K; Bai Y; Li Y; Ozaki T; Miyauchi A; Taniguchi E; Mori I
J Clin Pathol; 2011 Apr; 64(4):325-9. PubMed ID: 21296795
[TBL] [Abstract][Full Text] [Related]
17. Rewiring of the apoptotic TGF-β-SMAD/NFκB pathway through an oncogenic function of p27 in human papillary thyroid cancer.
Garcia-Rendueles AR; Rodrigues JS; Garcia-Rendueles ME; Suarez-Fariña M; Perez-Romero S; Barreiro F; Bernabeu I; Rodriguez-Garcia J; Fugazzola L; Sakai T; Liu F; Cameselle-Teijeiro J; Bravo SB; Alvarez CV
Oncogene; 2017 Feb; 36(5):652-666. PubMed ID: 27452523
[TBL] [Abstract][Full Text] [Related]
18. Programmed Death-Ligand 1 Expression in Papillary Thyroid Cancer and Its Correlation with Clinicopathologic Factors and Recurrence.
Shi RL; Qu N; Luo TX; Xiang J; Liao T; Sun GH; Wang Y; Wang YL; Huang CP; Ji QH
Thyroid; 2017 Apr; 27(4):537-545. PubMed ID: 27825291
[TBL] [Abstract][Full Text] [Related]
19. Clinicopathological significance of cancer-associated fibroblasts in papillary thyroid carcinoma: a predictive marker of cervical lymph node metastasis.
Cho JG; Byeon HK; Oh KH; Baek SK; Kwon SY; Jung KY; Woo JS
Eur Arch Otorhinolaryngol; 2018 Sep; 275(9):2355-2361. PubMed ID: 30019191
[TBL] [Abstract][Full Text] [Related]
20. Role of laminin 332 in lymph node metastasis of papillary thyroid carcinoma.
Oh KH; Choi J; Woo JS; Baek SK; Jung KY; Koh MJ; Kim YS; Kwon SY
Auris Nasus Larynx; 2017 Dec; 44(6):729-734. PubMed ID: 28238469
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
